'<?xml version="1.0" encoding="UTF-8"?>\r\n<ReportSnapshot Major="1" Minor="0" Revision="1">\r\n\t<CoIDs>\r\n\t\t<CoID Type="RepNo">A038A</CoID>\r\n\t\t<CoID Type="CompanyName">Cryolife Inc</CoID>\r\n\t\t<CoID Type="IRSNo">592417093</CoID>\r\n\t\t<CoID Type="CIKNo">0000784199</CoID>\r\n\t</CoIDs>\r\n\t<Issues>\r\n\t\t<Issue ID="1" Type="C" Desc="Common Stock" Order="1">\r\n\t\t\t<IssueID Type="Name">Ordinary Shares</IssueID>\r\n\t\t\t<IssueID Type="Ticker">CRY</IssueID>\r\n\t\t\t<IssueID Type="CUSIP">228903100</IssueID>\r\n\t\t\t<IssueID Type="ISIN">US2289031005</IssueID>\r\n\t\t\t<IssueID Type="RIC">CRY</IssueID>\r\n\t\t\t<IssueID Type="SEDOL">2239017</IssueID>\r\n\t\t\t<IssueID Type="DisplayRIC">CRY.N</IssueID>\r\n\t\t\t<IssueID Type="InstrumentPI">319068</IssueID>\r\n\t\t\t<IssueID Type="QuotePI">1094717</IssueID>\r\n\t\t\t<Exchange Code="NYSE" Country="USA">New York Stock Exchange</Exchange>\r\n\t\t\t<MostRecentSplit Date="2000-12-28">1.5</MostRecentSplit>\r\n\t\t</Issue>\r\n\t\t<Issue ID="2" Type="P" Desc="Preferred Stock" Order="1">\r\n\t\t\t<IssueID Type="Name">Preference Shares</IssueID>\r\n\t\t\t<IssueID Type="Ticker">CRY PR</IssueID>\r\n\t\t\t<IssueID Type="CUSIP">228903209</IssueID>\r\n\t\t\t<IssueID Type="ISIN">US2289032094</IssueID>\r\n\t\t\t<IssueID Type="RIC">CRY_p.N^F07</IssueID>\r\n\t\t\t<IssueID Type="InstrumentPI">19911813</IssueID>\r\n\t\t\t<IssueID Type="QuotePI">19914377</IssueID>\r\n\t\t\t<Exchange Code="NYSE" Country="USA">New York Stock Exchange</Exchange>\r\n\t\t</Issue>\r\n\t</Issues>\r\n\t<CoGeneralInfo>\r\n\t\t<CoStatus Code="1">Active</CoStatus>\r\n\t\t<CoType Code="EQU">Equity Issue</CoType>\r\n\t\t<LastModified>2019-09-19</LastModified>\r\n\t\t<LatestAvailableAnnual>2018-12-31</LatestAvailableAnnual>\r\n\t\t<LatestAvailableInterim>2019-06-30</LatestAvailableInterim>\r\n\t\t<Employees LastUpdated="2018-12-31">1100</Employees>\r\n\t\t<SharesOut Date="2019-07-18" TotalFloat="36044803.0">37495602.0</SharesOut>\r\n\t\t<CommonShareholders Date="2018-12-31">232</CommonShareholders>\r\n\t\t<ReportingCurrency Code="USD">U.S. Dollars</ReportingCurrency>\r\n\t\t<MostRecentExchange Date="2019-10-04">1.0</MostRecentExchange>\r\n\t</CoGeneralInfo>\r\n\t<TextInfo>\r\n\t\t<Text Type="Business Summary" lastModified="2017-03-06T22:00:34">CryoLife, Inc. (CryoLife) is a medical device manufacturer and processor, and is engaged in the distribution of medical devices and implantable human tissues used in cardiac surgical procedures. The Company operates through two segments: Medical Devices and Preservation Services. The Medical Devices segment includes medical devices, such as BioGlue Surgical Adhesive, BioFoam Surgical Matrix, On-X Life Technologies Holdings, Inc. valves and surgical products, CardioGenesis cardiac laser therapy product line, PerClot and PhotoFix. PhotoFix is a pericardial patch stabilized using a dye-mediated photo-fixation process that requires no glutaraldehyde. The Preservation Services segment includes external services, such as preservation of cardiac and vascular tissues. The cardiac and vascular human tissues distributed by CryoLife include the CryoValve SG pulmonary heart valve and the CryoPatch SG pulmonary cardiac patch, both of which are processed using CryoLife\'s SynerGraft technology.</Text>\r\n\t\t<Text Type="Financial Summary" lastModified="2019-09-19T07:36:48">BRIEF: For the six months ended 30 June 2019, Cryolife Inc revenues increased 6% to $138.6M. Net income applicable to common stockholders totaled $2.5M vs. loss of $3.6M. Revenues reflect Medical Devices segment increase from $49.3M to $99.6M, Preservation services segment increase from $19.2M to $39.1M. Net Income reflects Other (income) expense, net decrease of 80% to $262K (expense), General, administrative.</Text>\r\n\t</TextInfo>\r\n\t<contactInfo lastUpdated="2019-09-19T07:37:18">\r\n\t\t<streetAddress line="1">1655 Roberts Blvd NW</streetAddress>\r\n\t\t<streetAddress line="2"></streetAddress>\r\n\t\t<streetAddress line="3"></streetAddress>\r\n\t\t<city>KENNESAW</city>\r\n\t\t<state-region>GA</state-region>\r\n\t\t<postalCode>30144-3632</postalCode>\r\n\t\t<country code="USA">United States</country>\r\n\t\t<contactName>Greg Chodaczek</contactName>\r\n\t\t<contactTitle>IR Contact Officer</contactTitle>\r\n\t\t<phone>\r\n\t\t\t<phone type="mainphone">\r\n\t\t\t\t<countryPhoneCode>1</countryPhoneCode>\r\n\t\t\t\t<city-areacode>770</city-areacode>\r\n\t\t\t\t<number>4193355</number>\r\n\t\t\t</phone>\r\n\t\t\t<phone type="mainfax">\r\n\t\t\t\t<countryPhoneCode>1</countryPhoneCode>\r\n\t\t\t\t<city-areacode>770</city-areacode>\r\n\t\t\t\t<number>4260031</number>\r\n\t\t\t</phone>\r\n\t\t\t<phone type="contactphone">\r\n\t\t\t\t<countryPhoneCode>1</countryPhoneCode>\r\n\t\t\t\t<city-areacode>646</city-areacode>\r\n\t\t\t\t<number>9241769</number>\r\n\t\t\t</phone>\r\n\t\t</phone>\r\n\t</contactInfo>\r\n\t<webLinks lastUpdated="2012-06-04T06:43:55"><webSite mainCategory="Home Page">http://www.cryolife.com</webSite><eMail mainCategory="Company Contact/E-mail">investors@cryolife.com</eMail></webLinks>\r\n\t<peerInfo lastUpdated="2019-09-19T07:37:18">\r\n\t\t<IndustryInfo>\r\n\t\t\t<Industry type="TRBC" order="1" reported="0" code="5610102010" mnem="">Medical Equipment, Supplies &amp; Distribution - NEC</Industry>\r\n\t\t\t<Industry type="NAICS" order="1" reported="0" code="339112" mnem="">Surgical and Medical Instrument Manufacturing</Industry>\r\n\t\t\t<Industry type="NAICS" order="2" reported="0" code="339113" mnem="">Surgical Appliance and Supplies Manufacturing</Industry>\r\n\t\t\t<Industry type="SIC" order="0" reported="1" code="3841" mnem="">Surgical And Medical Instruments</Industry>\r\n\t\t\t<Industry type="SIC" order="1" reported="0" code="3841" mnem="">Surgical And Medical Instruments</Industry>\r\n\t\t\t<Industry type="SIC" order="2" reported="0" code="3842" mnem="">Surgical Appliances And Supplies</Industry>\r\n\t\t</IndustryInfo>\r\n\t\t<Indexconstituet>S&amp;P 600 Small Cap</Indexconstituet>\r\n\t</peerInfo>\r\n\t<officers>\r\n\t\t<officer rank="1" since="09/02/2014">\r\n\t\t\t<firstName>James</firstName>\r\n\t\t\t<mI>Patrick</mI>\r\n\t\t\t<lastName>Mackin</lastName>\r\n\t\t\t<age>52 </age>\r\n\t\t\t<title startYear="2015" startMonth="04" startDay="10" iD1="CHM" abbr1="Chmn." iD2="PRE" abbr2="Pres.">Chairman of the Board, President, Chief Executive Officer, Director</title>\r\n\t\t</officer>\r\n\t\t<officer rank="2" since="12/1994">\r\n\t\t\t<firstName>D. Ashley</firstName>\r\n\t\t\t<mI></mI>\r\n\t\t\t<lastName>Lee</lastName>\r\n\t\t\t<age>54 </age>\r\n\t\t\t<title startYear="2004" startMonth="11" startDay="03" iD1="CFO" abbr1="CFO" iD2="COO" abbr2="COO">Chief Financial Officer, Chief Operating Officer, Executive Vice President</title>\r\n\t\t</officer>\r\n\t\t<officer rank="3" since="2015">\r\n\t\t\t<firstName>Jean</firstName>\r\n\t\t\t<mI>F.</mI>\r\n\t\t\t<lastName>Holloway</lastName>\r\n\t\t\t<age>61 </age>\r\n\t\t\t<title startYear="2016" startMonth="01" startDay="" iD1="SVP" abbr1="Sr. VP" iD2="CCO" abbr2="Chief Comp.">Senior Vice President, Chief Compliance Officer, General Counsel, Secretary</title>\r\n\t\t</officer>\r\n\t\t<officer rank="4" since="09/08/2015">\r\n\t\t\t<firstName>John</firstName>\r\n\t\t\t<mI>E.</mI>\r\n\t\t\t<lastName>Davis</lastName>\r\n\t\t\t<age>54 </age>\r\n\t\t\t<title startYear="2015" startMonth="09" startDay="08" iD1="SVP" abbr1="Sr. VP" iD2="DSL" abbr2="Dir.-Sales">Senior Vice President - Global Sales and Marketing</title>\r\n\t\t</officer>\r\n\t\t<officer rank="5" since="12/2018">\r\n\t\t\t<firstName>Michael</firstName>\r\n\t\t\t<mI>S.</mI>\r\n\t\t\t<lastName>Simpson</lastName>\r\n\t\t\t<age>51 </age>\r\n\t\t\t<title startYear="2018" startMonth="12" startDay="" iD1="SVP" abbr1="Sr. VP" iD2="" abbr2="">Senior Vice President, Regulatory Affairs and Quality Assurance</title>\r\n\t\t</officer>\r\n\t\t<officer rank="6" since="08/07/2006">\r\n\t\t\t<firstName>Amy</firstName>\r\n\t\t\t<mI>D.</mI>\r\n\t\t\t<lastName>Horton</lastName>\r\n\t\t\t<age>47 </age>\r\n\t\t\t<title startYear="2016" startMonth="01" startDay="" iD1="CAO" abbr1="CAO" iD2="VPR" abbr2="VP">Chief Accounting Officer, Vice President</title>\r\n\t\t</officer>\r\n\t\t<officer rank="7" since="11/2007">\r\n\t\t\t<firstName>Scott</firstName>\r\n\t\t\t<mI>B.</mI>\r\n\t\t\t<lastName>Capps</lastName>\r\n\t\t\t<age>52 </age>\r\n\t\t\t<title startYear="2007" startMonth="11" startDay="" iD1="VPR" abbr1="VP" iD2="" abbr2="">Vice President - Clinical Research</title>\r\n\t\t</officer>\r\n\t</officers>\r\n\t<Ratios PriceCurrency="USD" ReportingCurrency="USD" ExchangeRate="1.00000" LatestAvailableDate="2019-06-30">\r\n\t\t<Group ID="Price and Volume">\r\n\t\t\t<Ratio FieldName="NPRICE" Type="N">24.40000</Ratio>\r\n\t\t\t<Ratio FieldName="NHIG" Type="N">33.78000</Ratio>\r\n\t\t\t<Ratio FieldName="NLOW" Type="N">23.94000</Ratio>\r\n\t\t\t<Ratio FieldName="PDATE" Type="D">2019-10-07T00:00:00</Ratio>\r\n\t\t\t<Ratio FieldName="VOL10DAVG" Type="N">0.24871</Ratio>\r\n\t\t\t<Ratio FieldName="EV" Type="N">1091.32270</Ratio>\r\n\t\t</Group>\r\n\t\t<Group ID="Income Statement">\r\n\t\t\t<Ratio FieldName="MKTCAP" Type="N">914.89270</Ratio>\r\n\t\t\t<Ratio FieldName="TTMREV" Type="N">271.04100</Ratio>\r\n\t\t\t<Ratio FieldName="TTMEBITD" Type="N">33.82500</Ratio>\r\n\t\t\t<Ratio FieldName="TTMNIAC" Type="N">3.06100</Ratio>\r\n\t\t</Group>\r\n\t\t<Group ID="Per share data">\r\n\t\t\t<Ratio FieldName="TTMEPSXCLX" Type="N">0.08009</Ratio>\r\n\t\t\t<Ratio FieldName="TTMREVPS" Type="N">7.28208</Ratio>\r\n\t\t\t<Ratio FieldName="QBVPS" Type="N">7.53232</Ratio>\r\n\t\t\t<Ratio FieldName="QCSHPS" Type="N">1.06108</Ratio>\r\n\t\t\t<Ratio FieldName="TTMCFSHR" Type="N">0.55902</Ratio>\r\n\t\t\t<Ratio FieldName="TTMDIVSHR" Type="N">0.00000</Ratio>\r\n\t\t</Group>\r\n\t\t<Group ID="Other Ratios">\r\n\t\t\t<Ratio FieldName="TTMGROSMGN" Type="N">66.09480</Ratio>\r\n\t\t\t<Ratio FieldName="TTMROEPCT" Type="N">1.10577</Ratio>\r\n\t\t\t<Ratio FieldName="TTMPR2REV" Type="N">3.37548</Ratio>\r\n\t\t\t<Ratio FieldName="PEEXCLXOR" Type="N">304.65730</Ratio>\r\n\t\t\t<Ratio FieldName="PRICE2BK" Type="N">3.23938</Ratio>\r\n\t\t\t<Ratio FieldName="Employees" Type="N">1100</Ratio>\r\n\t\t</Group>\r\n\t</Ratios>\r\n\t<ForecastData ConsensusType="Mean" CurFiscalYear="2019" CurFiscalYearEndMonth="12" CurInterimEndCalYear="2019" CurInterimEndMonth="9" EarningsBasis="PRX">\r\n\t\t<Ratio FieldName="ConsRecom" Type="N">\r\n\t\t\t<Value PeriodType="CURR">1.6667</Value>\r\n\t\t</Ratio>\r\n\t\t<Ratio FieldName="TargetPrice" Type="N">\r\n\t\t\t<Value PeriodType="CURR">36.10000</Value>\r\n\t\t</Ratio>\r\n\t\t<Ratio FieldName="ProjLTGrowthRate" Type="N">\r\n\t\t\t<Value PeriodType="CURR">-99999.99000</Value>\r\n\t\t</Ratio>\r\n\t\t<Ratio FieldName="ProjPE" Type="N">\r\n\t\t\t<Value PeriodType="CURR">82.01681</Value>\r\n\t\t</Ratio>\r\n\t\t<Ratio FieldName="ProjSales" Type="N">\r\n\t\t\t<Value PeriodType="CURR">281.33400</Value>\r\n\t\t</Ratio>\r\n\t\t<Ratio FieldName="ProjSalesQ" Type="N">\r\n\t\t\t<Value PeriodType="CURR">68.29000</Value>\r\n\t\t</Ratio>\r\n\t\t<Ratio FieldName="ProjEPS" Type="N">\r\n\t\t\t<Value PeriodType="CURR">0.29750</Value>\r\n\t\t</Ratio>\r\n\t\t<Ratio FieldName="ProjEPSQ" Type="N">\r\n\t\t\t<Value PeriodType="CURR">0.05500</Value>\r\n\t\t</Ratio>\r\n\t\t<Ratio FieldName="ProjProfit" Type="N">\r\n\t\t\t<Value PeriodType="CURR">11.40000</Value>\r\n\t\t</Ratio>\r\n\t\t<Ratio FieldName="ProjDPS" Type="N">\r\n\t\t\t<Value PeriodType="CURR">-99999.99000</Value>\r\n\t\t</Ratio>\r\n\t</ForecastData>\r\n</ReportSnapshot>\r\n'

